Key Takeaways
- Dr. Feng held the George and Judy Marcus Distinguished Professorship at UCSF.
- His research focused on identifying molecular determinants of treatment resistance in prostate cancer.
- He received the Mentorship Award from the American Society for Radiation Oncology in 2024.
Dr. Felix Feng, a renowned radiation oncologist and researcher specializing in prostate cancer, tragically passed away on December 10, 2024.
He was serving as the George and Judy Marcus Distinguished Professor at UCSF, where he held the position of Vice Chair for Translational Research in the Department of Radiation Oncology and as director of the Benioff Initiative for Prostate Cancer Research.
His demise marks a profound loss for both the medical and scientific communities.
Dr Feng’s passing has been met with an outpouring of grief and tributes from friends and colleagues.
On X (formerly Twitter), many shared their heartfelt condolences and memories of his life and work.
Marc Benioff, founder of Salesforce, wrote:
It is with profound sadness that we mourn the passing of Felix Feng—an incredible father, husband, UCSF leader, pioneering scientist, entrepreneur, mentor, and cherished friend. Felix’s enduring kindness, brilliant mind, generous spirit, and transformative work in prostate cancer… pic.twitter.com/5LuLfOp5bK
— Marc Benioff (@Benioff) December 11, 2024
Dr. Kaochar wrote:
Sadden to hear about @felixfengmd passing today. A true legend in GU. My deepest condolences to @MaryFengMD and the family. Felix will be deeply missed by our GU community as an incredible scientist and an amazing human being who was always very kind and always smiling.
Via X
Another friend and colleague posted:
💔😞 RIP, my friend @felixfengmd Please consider donating to the @AmericanCancer @ASTRO_org Felix Feng MD Clinician Scientist Grant Award. Let his incredible legacy live on.
Via X
Dr Feng earned his Bachelor of Science in Biological Sciences from Stanford University in 1998 and his medical degree from Washington University School of Medicine in St. Louis in 2002.
He completed his residency and fellowship in radiation oncology at the University of Michigan, where he later directed the Division of Translational Genomics and co-led the multidisciplinary clinic for prostate cancer patients.
In 2016, he joined UCSF, continuing his clinical practice and leading a research laboratory focused on identifying molecular determinants of treatment resistance in prostate cancer.
His work aims to develop targeted therapies to overcome such resistance, utilizing cutting-edge technologies, including artificial intelligence, to personalize treatment plans.
Dr Feng contributed to over 200 journal articles throughout his illustrious career and received numerous accolades, including the 2024 Mentorship Award from the American Society for Radiation Oncology.
ASTRO is pleased to announce the ACS-ASTRO Felix Feng, MD Clinician Scientist Development Grant Award, honoring the career & lifetime contributions of Felix Feng, MD, FASTRO. Make a pledge to support research in #RadOnc: https://t.co/xNWplI6cc7@felixfengmd @AmericanCancer pic.twitter.com/LiLZ5N9LvL
— ASTRO (@ASTRO_org) October 24, 2024
His enduring kindness, brilliant mind, and transformative work in prostate cancer research have touched and saved countless lives.
Dr Feng is survived by his wife, Dr Mary Feng, and their children, Eric and Emily.
His legacy continues to inspire ongoing research and mentorship in the field of oncology, reflecting his life’s work and commitment to improving patient outcomes.
In Case You Didn’t Know
- Felix Feng was born in Stamford, Connecticut, while his parents were pursuing their education there.
- He is of Chinese descent.
- His wife, Mary, specializes in radiation oncology and liver cancer.
